Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of itopride hydrochloride 50 mg tablets in healthy Thai volunteers
TCTR20211103001Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of mosapride (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax at 24 hours, AUC0-t at 24 hours and 1 more. Started May 2022; status: completed.
02
Drugs
mosapride
Beyond the preview
Go deeper on TCTR20211103001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211103001.